Masimo impressed with a robust earnings report driven by its healthcare segment, despite challenges from non-healthcare operations.

This quarter, Masimo saw significant growth in its healthcare segment. Healthcare revenue rose to $343.9 million, surpassing ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...

9 In 2005, Masimo introduced rainbow ® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively ...